PhD David Jurnečka

PhD David Jurnečka
no.: 58964 source: ARIS

researcher – active in research organisation
  david.jurneckaat signijs.si
Edit
Research activity

Code Science Field Subfield
1.05.00  Natural sciences and mathematics  Biochemistry and molecular biology   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
84.32
A''
14.74
A'
55.91
A1/2
75.67
CI10
112
CImax
23
h10
6
A1
0.32
A3
0
Data for the last 5 years (citations for the last 10 years) on May 8, 2026; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 14  132  110  7.86 
Scopus 14  133  111  7.93 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Doctoral degree  Ph. D.     CZ 2020 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  Jožef Stefan Institute  Odsek za biokemijo, molekularno in strukturno biologijo (Slovene)  2/15/2024  Assistant  Researcher  Teaching Assistant with Doctorate 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. GC-0005  Bridging oligonucleotide-based therapeutic upregulation of translation (BOOST)   7/1/2025 - 6/30/2028  PhD Roman Jerala   7,945 
2. J1-60007  The role of the microbiome in the life and death of bloom-forming jellyfish (JELLY-BIOME)   5/1/2025 - 4/30/2028  PhD Tinkara Tinta   2,392 
3. J1-60006  Boron-rich peptides and proteins for the multimodal treatment of glioblastoma and other difficult-to-treat cancers with boron neutron capture therapy   1/1/2025 - 12/31/2027  PhD Martin Gazvoda   4,189 
4. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   10/1/2023 - 9/30/2026  PhD Nina Kostevšek   4,488 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0140  Proteolysis and its regulation in health and disease   1/1/2022 - 12/31/2027 PhD Boris Turk   4,005 
Confirmation required
Views history
Favourite